GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CanBas Co Ltd (TSE:4575) » Definitions » Price-to-Owner-Earnings

CanBas Co (TSE:4575) Price-to-Owner-Earnings : (As of Apr. 27, 2024)


View and export this data going back to 2009. Start your Free Trial

What is CanBas Co Price-to-Owner-Earnings?

As of today (2024-04-27), CanBas Co's share price is 円448.00. CanBas Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for CanBas Co's Price-to-Owner-Earnings or its related term are showing as below:


TSE:4575's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 31.62
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-04-27), CanBas Co's share price is 円448.00. CanBas Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円-66.13. Therefore, CanBas Co's PE Ratio for today is At Loss.

As of today (2024-04-27), CanBas Co's share price is 円448.00. CanBas Co's EPS without NRI for the trailing twelve months (TTM) ended in was 円-68.01. Therefore, CanBas Co's PE Ratio without NRI for today is At Loss.

During the past 13 years, CanBas Co's highest PE Ratio without NRI was 34.64. The lowest was 0.00. And the median was 7.27.


CanBas Co Price-to-Owner-Earnings Historical Data

The historical data trend for CanBas Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanBas Co Price-to-Owner-Earnings Chart

CanBas Co Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CanBas Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CanBas Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, CanBas Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanBas Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CanBas Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where CanBas Co's Price-to-Owner-Earnings falls into.



CanBas Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

CanBas Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=448.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanBas Co  (TSE:4575) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


CanBas Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of CanBas Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


CanBas Co (TSE:4575) Business Description

Traded in Other Exchanges
N/A
Address
9 Toriyoko-cho, Shizuoka, JPN, 410-0891
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.

CanBas Co (TSE:4575) Headlines

No Headlines